Related Experiment Video
Updated: Jul 5, 2026
07:17
Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats
Published on: January 19, 2024
Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex
Philippe Major1, Elizabeth A Thiele
1Department of Neurology and Pediatrics, Massachusetts General Hospital, Boston, MA 02114, USA.
Epilepsy & Behavior : E&B
|May 13, 2008
Summary
Vagus nerve stimulation (VNS) shows promise for treating intractable epilepsy in patients with tuberous sclerosis complex (TSC). This therapy can reduce seizure frequency and improve functioning in many individuals with TSC.
Area of Science:
- Neurology
- Epileptology
- Medical Devices
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder that can cause epilepsy.
- Intractable epilepsy in TSC patients often requires advanced treatment options.
Purpose of the Study:
- To evaluate the efficacy and safety of vagus nerve stimulation (VNS) for treating intractable epilepsy in patients with TSC.
Main Methods:
- Retrospective study of 16 patients with TSC who received VNS implantation.
- Analysis of seizure frequency reduction and functional improvement.
Main Results:
- VNS efficacy varied, with 19% achieving >80% seizure reduction and 31% experiencing 50-79% reduction.
- 50% of patients found intermittent magnet use effective for seizure termination.
- 31% of patients reported an improved level of functioning.
Conclusions:
- Vagus nerve stimulation appears to be an effective and safe therapeutic option for individuals with TSC and intractable epilepsy.
- VNS may offer seizure control and functional benefits for this patient population.
